Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Breast Cancer Screening topic
No spam. Unsubscribe anytime.
Sonoditech representative promotes early breast‑cancer screening technology and local discount in meeting remarks
Summary
An unidentified Sonoditech representative told a meeting the clinic offers Sonosine robotic screening that can detect tumors as small as 3 millimeters, an epigenetic optimization test, specialist consultations and a 10% discount for Doral residents under a local program.
An unidentified Sonoditech representative told a meeting that the clinic offers early breast‑cancer screening with Sonosine robotic technology and an epigenetic optimization test aimed at preventive care.
The speaker said Sonoditech provides personalized care and specialists for breast sonography, a surgical assistant who advises on mastology consultations, and health coaches who guide patients on healthy lifestyles. “Somos el único centro con la tecnología Sonosine, que funciona para detección precoz de cáncer de mama, y también utilizamos un test de optimización epigenética para guiar a nuestras pacientes en una vida preventiva para evitar enfermedades,” the speaker said in Spanish (translation: “We are the only center with Sonosine technology, which works for early detection of breast cancer, and we also use an epigenetic optimization test to guide our patients toward preventive lifestyles to avoid disease”).
The speaker described the Sonosine system as capable of detecting cancers “hasta tres milímetros” (as small as 3 millimeters) and said the clinic uses that technology for pre‑purchase detection screening and personalized follow‑up. The remarks also noted the clinic’s multidisciplinary approach, listing a specialist in breast sonography, a surgical assistant for mastology consultations, and health coaches available to patients of any age.
The representative invited listeners to visit Sonoditech and follow the clinic on social media. They also said the clinic participates in a program called “Seis Local Spend Local,” under which Sonoditech offers a 10% discount to all Doral residents.
The remarks appear in the meeting transcript as recorded comments and do not record any formal action, vote, or endorsement by the meeting body. No funding, regulatory approvals, clinical outcomes, or independent performance data for the Sonosine technology or the epigenetic test were provided in the recorded remarks.
